Incidence and predictors of pericardial effusion after permanent heart rhythm device implantation - Prospective evaluation of 968 consecutive patients -

Circulation Journal

Volumn 77, Issue 4, 2013, Pages 975-981

  Ohlow, Marc Alexander ^a   Lauer, Bernward ^a   Brunelli, Michele ^a   Christoph Geller, J ^a  

^a Zentralklinik Bad Berka ^*  (Germany)

Author keywords

Implantable cardioverter defibrillator; Pacemaker; Pericardial effusion; Resynchronization therapy; Tamponade

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC IMPLANT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CAUTERIZATION; DOPPLER FLOWMETER; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART PACING; HEART TAMPONADE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PERICARDIAL EFFUSION; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84875520335     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0707     Document Type: Article

References (29)

1. Ellenbogen K, Wood M, Shepard R. Delayed complications following pacemaker implantation. Pacing Clin Electrophysiol 2002; 25: 1155-1158.
2. Burney K, Burchardt F, Papouchado M, Wilde P. Cardiac pacing systems and implantable cardioverter defibrillators: A radiological perspective of equipment, anatomy, and complications. Clin Radiol 2004; 59: 699-708.
3. Reynolds M, Cohen D, Kugelmass A, Brown P, Becker E, Culler S, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497.
4. Aizawa K, Kaneoko Y, Yamagishi T, Utsugi T, Suzuki T, Ishikawa S, et al. Oozing from the pericardium as an etiology of cardiac tamponade associated with screw-in atrial leads. Pacing Clin Electrophysiol 2001; 24: 381-383.
5. Mahapatra S, Bybee K, Bunch J, Espinosa R, Sinak L, McGoon M, et al. Incidence and predictors of cardiac perforation after permanent pacemaker implantation. Heart Rhythm 2005; 2: 907-911.
6. Roeland J, Erbel R. Cardiac ultrasound. In: Camm J, Luescher T, Serruys P, editors. The ESC textbook of cardiovascular medicine. Oxford, UK: Blackwell Publishing, 2006; 84-87.
7. Levy Y, Shovman O, Granit C, Luria D, Gurevitz O, Bar-Lev D, et al. Pericarditis following permanent pacemaker insertion. Isr Med Assoc J 2004; 6: 599-602.
8. Hirschl D, Jain V, Spindola-Franco H, Gross J, Haramati L. Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT. Pacing Clin Electrophysiol 2007; 30: 28-32.
9. Hill P. Complications of permanent transvenous cardiac pacing: A 14-year review of all transvenous at one community hospital. Pacing Clin Electrophysiol 1987; 10: 564-570.
10. Sivakumaran S, Irvin M, Gulamhusein S, Senaratne M. Post pacemaker implant pericarditis: Incidence and outcomes with active fixation leads. Pacing Clin Electrophysiol 2002; 25: 833-837.
11. Danik S, Mansour M, Singh J, Reddy V, Ellinor P, Milan D, et al. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 2007; 4: 439-442.
12. Kholova I, Kautzner J. Morphology of atrial myocardial extensions into human veins: A post-mortem study in patients with and without atrial fibrillation. Circulation 2004; 110: 483-488.
13. Kaye D, Frankl W, Arditi L. Probable postcardiotomy syndrome following implantation of a transvenous pacemaker: Report of the first case. Am Heart J 1975; 90: 627-630.
14. Greene T, Portnow A, Huang S. Acute pericarditis resulting from an endocardial active fixation screw-in atrial lead. Pacing Clin Electrophysiol 1994; 17: 21-25.
15. Cevik C, Wilborn T, Corona R, Schanzmeyer E, Nugent K. Postcardiac injury syndrome following transvenous pacemaker insertion: A case report and review of literature. Heart Lung Circ 2009; 18: 379-383.
16. Geyfman V, Storm R, Lico S, Oren J. Cardiac tamponade as complication of active-fixation atrial lead perforations: Proposed mechanism and management algorithm. Pacing Clin Electrophysiol 2007; 30: 498-501.
17. Ishikawa K, Cida K, Taniguchi T. Myocardial perforation and/or penetration by an endocardial electrode of the permanent pacemaker in autopsy cases. J Arrhythmia 1999; 15: 29-44.
18. Khan AH. The post cardiac injury syndrome. Clin Cardiol 1992; 15: 67-71.
19. Cabalka A, Rosenblatt H, Towbin J. Postpericardiotomy syndrome in pediatric heart transplant recipients: Immunologic characteristics. Tex Heart Inst J 1995; 22: 170-174.
20. Wong C, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marvick T. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081-3087.
21. Alpert M. Obesity cardiomyopathy: Pathophysiology and evolution of a clinical syndrome. Am J Med 2001; 321: 225-236.
22. McQuillan M, Picard M, Leavitt M, Weyman A. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographic normal subjects. Circulation 2001; 104: 2797-2802.
23. Rich S, McLaughlin V. Pulmonary hypertension. In: Zipes D, Libby P, Bonnow R, editors. Braunwald's heart disease (7th edn). Philadelphia: Elsevier, 2004; 1807-1842.
24. Ohlow MA, Lauer B, Lotze U, Brunelli M, Geller JC. Long-term prognosis of adult patients with isolated congenital left ventricular aneurysm or diverticulum and abnormal electrocardiogram patterns. Circ J 2012; 76: 2465-2470.
25. Momomura S, Tsutsui H, Sugawara Y, Ito M, Mitsuhashi T, Fukamizu S, et al; MOMIJI Study Investigators. Clinical efficacy of cardiac resynchronization therapy with an implantable defibrillator in a Japanese population: Results of the MIRACLE-ICD outcome measured in Japanese indication (MOMIJI) study. Circ J 2012; 76: 1911-1919.
26. Kuvin J, Harati N, Pandian N, Bojar R, Khabbaz K. Postoperative cardiac tamponade in the modern surgical era. Ann Thorac Surg 2002; 74: 1148-1153.
27. Tompkins C, Cheng A, Dalal D, Brinker J, Leng C, Marine J, et al. Dual antiplatelet therapy significantly increases the risk of bleeding complications after pacemaker or ICD device placement. J Am Coll Cardiol 2010; 55: 2376-2382.
28. Haines D, Wang Y, Curtis Y. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation 2011; 123: 2069-2076.
29. Maesato A, Higa S, Lin YJ, Chinen I, Ishigaki S, Yajima M, et al. Impact of pacing and high-pass filter settings on ventricular bipolar electrograms in implantable cardioverter defibrillator systems: Implication of predictors for inappropriate therapy caused by oversensing of repolarization electrograms. Circ J 2011; 75: 2095-2104.